Dr. David Coleman Wilson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2203 Graves Mill Rd, Suite A, Forest, VA 24551 Phone: 434-385-1982 Fax: 434-385-1985 |
News Archive
MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.
Dr. Horea Rus is an expert in diagnosing and treating patients with multiple sclerosis, and his research laboratory at the University of Maryland is producing new tools for treating the disease that attacks the central nervous system.
The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of its New Therapy Grants Program, a unique joint venture of the non-profit epilepsy organizations, to advance promising epilepsy research in clinical development. The grant awards, totaling approximately $200,000 in funding, will support an experimental gene therapy that directly targets epileptogenic brain tissue, as well as an electrode system that has the potential to improve the efficacy of surgical therapies for certain epilepsy syndromes.
PHT Corporation announced today the availability of the electronic version of the DHP-18 (Diabetes Health Profile) Quality of Life (QoL) questionnaire on all of its electronic patient reported outcome (ePRO) collection modalities - smartphone, tablet and Web. PHT is the global pacesetter in PRO and ePRO solutions that maximize the collection of high-quality data from clinical trial patients to improve clinical trial efficiencies.
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
› Verified 6 days ago